Uric Acid: Nursing Guide
Uric acid is the end product of purine metabolism — when blood levels rise, crystals may deposit in joints or kidneys, yet a single chemistry value does not diagnose an acute gout flare and can be normal during attacks. Nurses support safe testing with correct venous collection, medicine review (loop diuretics and low-dose aspirin may raise levels), and honest communication: pair serum uric acid with examination, synovial fluid analysis when ordered, renal function, and inflammatory markers — not memorized universal thresholds.
Contents
Quick Facts
Key Takeaway
Trend chemistry with renal function, diuretic and aspirin exposure, and inflammatory markers; escalate septic monoarthritis and critical laboratory flags per institutional policy.
Specimen & Collection Details
Nurse quick-reference for collection prep that affects result quality.
Gold-top SST or green-top heparin plasma per panel protocol
Serum separator or lithium heparin plasma per institutional BMP/CMP standard
Blood (venous serum or plasma; often on BMP or CMP)
Typically part of a chemistry panel — follow local laboratory minimum volume requirements
No universal fasting requirement for uric acid alone; collect with ordered BMP/CMP and document time when trending response to urate-lowering therapy
Fasting may be required when uric acid is part of a fasting BMP/CMP — follow the ordering clinician and laboratory requisition
Standard venous chemistry handling per laboratory policy; avoid hemolysis and prolonged delay before processing
Turnaround and screening rules vary by institution; follow local institutional policy as a universal value — institutional turnaround varies
Blood chemistry / clinical laboratory
What is Uric Acid?
Uric Acid measures uric acid — a waste product formed when the body breaks down purines from diet and cell turnover — in the blood. The kidneys excrete most uric acid; elevated levels (hyperuricemia) increase risk of gout and uric acid kidney stones but do not alone prove an acute inflammatory flare. Reviewed references note sex-specific hyperuricemia cutoffs (often above approximately 6 mg/dL in females and 7 mg/dL in males) while emphasizing laboratory-specific intervals.
Overview
Nurses encounter uric acid on emergency, rheumatology, and primary care pathways when adults report joint pain and joint swelling — especially hot, red first metatarsophalangeal (MTP) monoarthritis suggesting gout. Serum uric acid is useful for screening hyperuricemia, monitoring urate-lowering therapy, and evaluating recurrent stone disease, yet it may be normal or fall during an acute attack while crystals remain in the joint.
Loop diuretics such as furosemide and low-dose aspirin can raise uric acid, while urate-lowering medicines including allopurinol lower levels over weeks — colchicine treats flares but does not normalize chemistry. Pair uric acid with basic metabolic panel components, serum creatinine, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) when ordered; definitive crystal identification requires joint aspiration and synovial fluid microscopy when clinically indicated.
Before collection, confirm the order matches suspected hyperuricemia, gout workup, stone evaluation, or urate-lowering therapy monitoring. After results return, communicate elevated uric acid with focused joint and renal assessment — avoid telling patients a high value alone confirms gout during an acute flare. Escalate febrile monoarthritis, critical laboratory flags, and uric acid nephropathy concerns per facility policy.
Hyperuricemia, Gout Flare, and Crystal-versus-Chemistry Safety
Serum uric acid influences gout and stone discussions — yet it is not a standalone diagnosis during an acute flare. The most common nursing safety errors are treating hyperuricemia as definitive gout without synovial evaluation when ordered, missing febrile monoarthritis that may be septic, and starting urate-lowering therapy during an untreated flare without prescriber plan.
- Febrile hot monoarthritis attributed to gout without urgent septic workup
- Elevated uric acid communicated as proof of gout while joint aspiration is pending
- Independent allopurinol initiation during acute first MTP flare without prescriber review
- Critical chemistry panel flags not communicated per institutional policy
Document: uric acid with laboratory interval, joint examination, diuretic and aspirin exposure, prescriber notification, aspiration status, and escalation of febrile or renal deterioration.
What Serum Uric Acid Can and Cannot Tell You
This test can help identify:
- Hyperuricemia when paired with sex-specific laboratory reference intervals
- Gout risk and need for urate-lowering therapy monitoring when integrated with examination
- Contributors such as diuretics, low-dose aspirin, renal impairment, and diet history
- Stone prevention context when uric acid nephrolithiasis is in the differential
This test cannot:
- Diagnose acute crystal gout alone — synovial monosodium urate crystals are definitive when aspiration is performed
- Rule out gout when normal during an acute flare
- Replace joint aspiration, inflammatory markers, or septic arthritis evaluation when indicated
- Define universal critical uric acid limits — institution-specific escalation policies apply
Pre-draw Checks for Uric Acid and Chemistry Panels
Verify
Clarify before proceeding when:
- Order indication does not match symptoms (e.g., isolated fatigue without gout or stone history)
- Duplicate uric acid recently resulted and repeat timing is unclear
- Febrile monoarthritis present but no septic workup or aspiration plan documented
- Wrong tube type is available (EDTA when serum chemistry is required)
- Patient identity or label mismatch risk is present
- Hyperuricemia previously noted but urate-lowering follow-up was never arranged
Synovial Crystals Versus Serum Uric Acid
Monosodium urate crystals in synovial fluid — identified with compensated polarized microscopy after aspiration — remain the reference standard for definitive gout when the procedure is performed. Serum uric acid reflects circulating purine load and renal excretion but may fall toward normal during acute inflammation while crystals persist in the joint.
| Assessment layer | What it shows | Nursing takeaway |
|---|---|---|
| Serum uric acid (chemistry) | Hyperuricemia risk, urate-lowering response, stone context | Pair with sex-specific laboratory interval — not a flare on/off switch |
| Synovial fluid crystals (aspiration) | Needle-shaped negative birefringent monosodium urate | Support prescriber communication when aspiration is ordered — do not skip septic evaluation if febrile |
| Clinical examination | Hot swollen monoarthritis pattern (e.g., first MTP) | Document weight-bearing, fever, and spread — gout and septic arthritis overlap |
Reference ranges, critical values, and protocols may vary by laboratory, institution, analyzer, age, sex, and clinical context. Always interpret results using the reporting laboratory’s reference range and local escalation policy.
Reading Uric Acid With Crystals, Renal Function, and Flare Context
Integrate uric acid with joint examination, fever status, synovial fluid results when available, creatinine, inflammatory markers, stone history, and urate-lowering therapy plans. Chemistry alone should not start or stop aspiration, flare treatment, or long-term urate-lowering decisions.
| Clinical context | Pair with uric acid | Nursing focus |
|---|---|---|
| Acute first MTP flare | Markedly elevated uric acid | Notify prescriber; support pending aspiration — avoid definitive gout language from chemistry alone |
| Acute flare with normal uric acid | Compatible examination | Do not reassure that gout is excluded — crystals may still be present |
| Asymptomatic hyperuricemia on diuretic | Stable creatinine | Support medicine reconciliation and scheduled urate-lowering review per orders |
| Febrile monoarthritis | Any uric acid level | Prioritize septic evaluation pathway per facility policy regardless of chemistry |
Reference ranges, critical values, and protocols may vary by laboratory, institution, analyzer, age, sex, and clinical context. Always interpret results using the reporting laboratory’s reference range and local escalation policy.
Diuretics, Aspirin, and Crystal-versus-Chemistry Traps at the Bedside
| Bedside point | Nursing note |
|---|---|
| Crystal versus chemistry trap | Normal uric acid during a flare is common — do not cancel aspiration or flare orders based on chemistry alone |
| Diuretic effect | Loop diuretics may raise uric acid — reconcile furosemide before blaming diet alone |
| Aspirin nuance | Low-dose aspirin can raise uric acid; clarify hold or flare NSAID plan with prescriber |
| Urate-lowering timing | Do not start allopurinol during acute flare without prescriber prophylaxis plan |
| Sex-specific intervals | Use the reporting laboratory range — hyperuricemia thresholds differ by sex on many reports |
| Evaluate outcomes | Reassess after flare treatment and urate-lowering therapy — symptoms and trended chemistry matter more than one draw |
Why Uric Acid is Ordered
Uric acid is ordered when clinicians need chemistry support for hyperuricemia, gout risk, urate-lowering therapy monitoring, or stone evaluation — always interpreted with symptoms and related diagnostics.
| Clinical Indication | What the Test Answers | Nursing Rationale |
|---|---|---|
| Suspected gout or recurrent inflammatory monoarthritis | Does hyperuricemia support gout evaluation when paired with compatible examination? | Elevated uric acid increases gout probability in the right context but may be normal during flares — synovial crystal search when aspiration is performed remains definitive. |
| Monitoring urate-lowering therapy (allopurinol, febuxostat) | Is uric acid trending toward prescriber target on maintenance therapy? | Guidelines emphasize treat-to-target urate levels on long-term therapy — nurses track repeat chemistry, adherence, and flare prophylaxis per orders. |
| Recurrent uric acid kidney stones or nephrolithiasis workup | Does persistent hyperuricemia suggest need for stone prevention review? | Hyperuricemia contributes to uric acid stone formation — pair with renal function, urine studies, and hydration teaching when ordered. |
| Metabolic syndrome, CKD, or diuretic-associated hyperuricemia screening | Does chemistry add context when diuretics, obesity, or renal impairment are present? | Loop and thiazide diuretics, renal insufficiency, and high purine intake may elevate uric acid — interpret with medicines and creatinine trend. |
Contraindications and Precautions
There are no absolute contraindications to venous blood draw for uric acid. Nursing focus is on correct indication, chemistry specimen integrity, and safe interpretation rather than withholding the test.
- Febrile, hot, swollen monoarthritis — septic arthritis must be excluded before attributing symptoms to gout alone regardless of uric acid level.
- Critical laboratory flags on chemistry panels per institutional policy — complete critical-value read-back and prescriber notification.
- Acute kidney injury with marked hyperuricemia and oliguria — possible urate nephropathy pathway; escalate per facility policy.
- Normal or falling uric acid during an acute gout flare — do not rule out crystal arthritis.
- Starting urate-lowering therapy during an untreated acute flare without prescriber plan — may worsen symptoms; flare treatment and prophylaxis are prescriber-led.
- Loop diuretics, low-dose aspirin, alcohol, and high purine intake may elevate uric acid independent of gout activity.
- Febrile monoarthritis with inability to bear weight — urgent evaluation for septic arthritis.
- Rapidly worsening renal function with rising uric acid and decreasing urine output.
- Critical chemistry flags or prescriber-defined hyperuricemia thresholds per institutional escalation policy — do not invent universal critical limits at the bedside.
Patient Preparation
Most uric acid testing requires no special patient preparation beyond panel requirements. Preparation focuses on order verification, medicine review, and venous chemistry collection per institutional phlebotomy policy.
Pre-test checksDocument loop diuretics, thiazides, low-dose aspirin, niacin, cyclosporine, and urate-lowering therapy because they affect interpretation — do not stop medicines unless ordered. Clarify hold parameters for aspirin or NSAIDs during gout flare management with the prescriber.
Performance — nursing procedure guide
This page is a Tests & Diagnostics guide for Uric Acid. It emphasizes why the test is ordered, how to interpret results, when to escalate, and preparation factors that affect validity — not step-by-step performance technique (those live under Nursing Procedures when available).
Step-by-step technique, supplies, infection prevention, and immediate post-procedure monitoring for this test are covered in:
Use the Patient preparation, Results and interpretation, and Nursing responsibilities sections on this page for order verification, pre-analytic checks, result follow-up, critical-value escalation, and documentation.
Result follow-up at a glance
Nursing workflow on this page — from order to safe action on results:
Results and Interpretation
Uric acid is reported quantitatively in mg/dL (or µmol/L on some reports). Reference intervals vary by laboratory, age, and sex — many sources cite hyperuricemia above approximately 6 mg/dL in females and 7 mg/dL in males, but always use the reporting laboratory interval. Reference ranges, critical values, and protocols may vary by laboratory, institution, analyzer, age, sex, and clinical context. Always interpret results using the reporting laboratory’s reference range and local escalation policy.
Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.
| Result | Range / Finding | Clinical Meaning | Nursing Action |
|---|---|---|---|
| Within reference interval | Within reporting laboratory reference interval (sex-specific) | No current laboratory evidence of hyperuricemia at institutional cutoff | Continue clinical assessment; gout may still be present if crystals were identified — do not dismiss active monoarthritis based on normal uric acid alone |
| Borderline / near reference limit | High-normal or mild elevation per laboratory report | May warrant lifestyle review and repeat testing — significance increases with stone history, diuretic use, or compatible symptoms | Ensure clinician review; reinforce hydration and medicine reconciliation without independent urate-lowering changes |
| High / above reference interval | Above reporting laboratory reference interval / hyperuricemia | Supports hyperuricemia evaluation and gout risk in appropriate context — not definitive proof of acute crystal flare without examination or synovial studies | Notify prescriber; clarify need for joint aspiration, flare treatment, urate-lowering plan, and renal monitoring — do not start allopurinol independently during acute flare |
| Low / below reference interval | Below reporting laboratory reference interval (uncommon) | Rare — may reflect severe liver disease, SIADH context, or laboratory variation; interpret with clinical picture | Communicate to clinician with symptoms and concurrent chemistry — avoid independent diagnosis |
Urgent Uric Acid Escalation and Result Follow-Up
Uric acid critical thresholds are institution-specific — many laboratories do not report uric acid as a standalone critical value like potassium or troponin. Nursing urgency focuses on febrile monoarthritis, acute kidney injury with hyperuricemia, critical panel flags, and dangerous misinterpretation of chemistry during active flares.
| Critical Finding | Threshold / Value | Immediate Action |
|---|---|---|
| Febrile hot swollen joint with systemic symptoms | Temperature elevation with monoarthritis unable to bear weight | Escalate according to facility policy — septic arthritis must be excluded urgently even when gout is suspected and uric acid is elevated |
| Critical laboratory flags on chemistry panel | Institution-defined critical uric acid or paired renal/electrolyte flags | Complete critical-value notification and read-back per policy — do not apply memorized universal numeric cutoffs |
| Hyperuricemia with acute kidney injury and oliguria | Rising creatinine with falling urine output and markedly elevated uric acid | Notify prescriber urgently; support hydration and monitoring per orders — evaluate outcomes with repeat renal panel and urine output trends |
Stop routine reassurance and escalate according to facility policy when the patient develops febrile monoarthritis, critical laboratory flags, acute kidney injury with hyperuricemia, or when elevated uric acid has not triggered appropriate aspiration, flare, or urate-lowering follow-up.
Factors Affecting Results
Uric acid interpretation depends on sex-specific reference intervals, diuretic and aspirin exposure, renal function, timing relative to acute flares, and laboratory method. Nurses should recognize common false reassurance and over-call patterns.
- Assuming elevated uric acid alone confirms acute gout without examination or synovial crystal evidence
- Attributing every hyperuricemia result to dietary excess while missing diuretic or renal contributors
- Starting urate-lowering therapy during an active untreated flare without prescriber flare plan
- Normal uric acid during an acute gout attack — levels may fall while joint inflammation persists
- Dismissing gout after one normal chemistry value when classic MTP flare and positive crystals exist
- Ignoring hyperuricemia on CKD baseline because value is ‘expected’ without stone or flare monitoring
- Hemolysis, lipemia, or incorrect tube type affecting chemistry assays
- Loop diuretics, low-dose aspirin, alcohol, and high purine meals raising levels
- Different laboratory platforms and sex-specific reference intervals between sites
Serum uric acid cannot diagnose acute crystal gout alone — synovial monosodium urate crystals are the reference standard when aspiration is performed, and uric acid may be normal during flares. Hyperuricemia increases gout and uric acid stone risk but many people with elevated levels never develop symptoms. Results must be integrated with examination, renal function, inflammatory markers, stone history, and urate-lowering therapy plans per evidence-based gout guidance.
Nursing Responsibilities
Nursing responsibilities center on safe venipuncture, chemistry specimen integrity, medicine reconciliation, timely result follow-up, and preventing misinterpretation of uric acid at the bedside.
Before the TestDocumentation
Documentation should link specimen collection, result communication, joint assessment, and medicine context for uric acid chemistry.
“Uric acid collected 1030 with BMP; gold SST labeled at bedside; patient tolerated venipuncture. Assessment: 58-year-old with hot, swollen right first MTP, pain 8/10, afebrile; uric acid 9.8 mg/dL (above reporting laboratory interval). MAR: furosemide 40 mg daily, aspirin 81 mg daily; colchicine not yet given. Joint aspiration ordered — synovial fluid studies pending. Prescriber notified with examination findings and read-back per policy. Patient educated that elevated uric acid supports hyperuricemia evaluation but crystal identification may still be required.”
- Date, time, site, collector, and chemistry tube type
- Indication and related orders (BMP, creatinine, CRP, ESR, aspiration)
- Joint examination, fever status, and weight-bearing ability
- Result value with laboratory reference range and prior trend if available
- Prescriber notification, aspiration status, and urate-lowering or flare plan
- Patient education on serum uric acid limits and when to report worsening symptoms
Patient and Family Education
Patients often believe a high uric acid level always means gout or that normal levels exclude gout. Use clear language tied to symptoms, aspiration plans, and follow-up.
Uric Acid NCLEX practice questions
Practice NCLEX-style clinical judgment focused on Uric Acid safety and nursing judgment. Use the case tabs (orders, results, assessment, nursing notes), then answer eight Next Gen–style items (including an ordered workflow step) and evaluate outcomes with the answer key.
Select a tab to view orders, results, assessment, and nursing note details for this case.
- Order: Uric acid, serum — chemistry panel with BMP; joint aspiration pending
- Indication: 58-year-old with hot swollen right first MTP and gout concern
- Timing: Uric acid resulted today; joint aspiration scheduled this afternoon
- Related orders: Joint aspiration with synovial fluid analysis; BMP with creatinine; CRP and ESR pending
- Result: Uric acid 9.8 mg/dL — above reporting laboratory interval (hyperuricemia)
- Trend / prior value: Prior uric acid 7.4 mg/dL six months ago on same diuretic regimen
- Pending tests: Synovial fluid crystal search, CRP/ESR, and prescriber flare plan pending
- Vital signs: T 37.2°C, HR 88/min, BP 142/86 mmHg, RR 16/min, SpO₂ 97% on room air
- Symptoms: Hot, erythematous, swollen right first MTP; pain 8/10; difficulty bearing weight
- Focused assessment: Monoarticular first MTP inflammation without skin breaks; no other joints involved today
- Preparation notes: Patient asked if 9.8 mg/dL proves gout; nurse explained chemistry supports evaluation with examination and pending aspiration
- Collection events: BMP with uric acid collected 0845; labeled SST sent to lab 0855
- Teaching gaps / safety concerns: Elevated uric acid on furosemide and aspirin with acute monoarthritis — risk of treating as gout without excluding infection or crystal confirmation
Answer key & rationale
Frequently Asked Questions
FAQ
Why is uric acid ordered in suspected gout?
Uric acid helps identify hyperuricemia and monitor urate-lowering therapy. It supports gout evaluation in context but does not alone diagnose an acute flare — synovial crystal identification when aspiration is performed remains the reference standard.
Does the patient need to fast before uric acid testing?
Uric acid alone usually requires no fasting. Follow instructions on the requisition when it is part of a fasting BMP or CMP or when other timed chemistry tests are ordered on the same sample.
What uric acid level is considered high?
Use the reporting laboratory reference interval. Many references cite hyperuricemia above approximately 6 mg/dL in females and 7 mg/dL in males, but cutoffs vary by laboratory and patient context — do not apply memorized thresholds without the printed report.
Can uric acid diagnose gout by itself?
No. Elevated uric acid increases gout probability but acute gout is confirmed by compatible clinical findings and monosodium urate crystals in synovial fluid when aspiration is performed. Uric acid may be normal during an attack.
Why is uric acid normal in some gout flares?
During acute inflammation, serum uric acid may fall toward or into the reference interval while crystals remain in the joint. Nurses should not reassure patients that normal chemistry excludes gout when examination and aspiration findings suggest otherwise.
Which medicines affect uric acid results?
Loop and thiazide diuretics, low-dose aspirin, niacin, and some immunosuppressants may raise uric acid; allopurinol and febuxostat lower levels over time. Document MAR medicines and clarify hold or flare plans with the prescriber — do not stop drugs independently.
Do reference ranges vary between laboratories?
Yes. Intervals differ by analyzer, sex, and age. Always use the reference range printed on the patient’s result report and institutional escalation policy for critical notifications.
References
References
-
MedlinePlus. Uric Acid Test. U.S. National Library of Medicine.https://medlineplus.gov/lab-tests/uric-acid-test/
-
University of Rochester Medical Center. Uric Acid (Blood). Health Encyclopedia.https://www.urmc.rochester.edu/encyclopedia/content.aspx?contenttypeid=167&contentid=uric_acid_blood
-
Centers for Disease Control and Prevention. Gout. U.S. Department of Health and Human Services.https://www.cdc.gov/arthritis/gout/
-
National Institute of Arthritis and Musculoskeletal and Skin Diseases. Gout. National Institutes of Health.https://www.niams.nih.gov/health-topics/gout
-
Krishnan E. Hyperuricemia. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.https://www.ncbi.nlm.nih.gov/books/NBK537065/
-
National Heart, Lung, and Blood Institute. Blood Tests. U.S. Department of Health and Human Services.https://www.nhlbi.nih.gov/health/blood-tests
-
National Institute for Health and Care Excellence. Gout: diagnosis and management. NICE guideline NG219.https://www.nice.org.uk/guidance/ng219
-
Richette P; et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017.https://doi.org/10.1136/annrheumdis-2016-210627
Editorial Standards & Medical Review
About the author: Sid A. Abdala Balal, RN, writes evidence-based nursing education focused on diagnostic safety, clinical interpretation, and bedside nursing judgment.
Medical review: This guide is reviewed by Dr. Adam Sayedi, MD, for clinical accuracy, diagnostic safety, and alignment with current standards for Uric Acid.
Policies: Medical Review Process · Editorial Policy · Correction Policy